Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, has expanded its leadership position in the diagnostic pathology market. The company has grown its clinical customer base by more than 100% in the past year. Among its other highlights, Proscia was recognized by KLAS Research in a June 2024 Emerging Company Spotlight report and released findings from a study conducted with Quest Diagnostics, a leading provider of diagnostic information services, on the impact of its AI-enabled workflows.
Announcing insideAI NEWS – Illuminating AI’s Frontiers: Your Go-To News Destination
July 1, 2024 by
insideBIGDATA, the leading source for news and insights about artificial intelligence, is proud to announce the relaunch and rebranding of the publication as insideAI News. The revamped platform will offer comprehensive coverage of AI technology and implementation strategies across multiple industries, including healthcare, security, financial services, automation, and agriculture.
The Transformative Role of AI in the Healthcare Industry
June 27, 2024 by
In this feature article, Daniel D. Gutierrez, insideAInews Editor-in-Chief & Resident Data Scientist, discusses how the integration of AI into healthcare systems promises to enhance patient care, streamline clinical operations, and foster innovative research, marking a significant shift in how medical services are delivered and experienced.
AI-based Small Molecule Therapeutics Pioneer Athos Therapeutics Selects Vultr for Secure AI Training in the Cloud
June 18, 2024 by
Vultr, the large, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. Powered by NVIDIA HGX H100 systems and running on Dell Technologies’ PowerEdge XE9680 servers, Vultr now offers Athos the needed security and confidentiality for their intellectual property, omics data, and proprietary AI algorithms.
How Can Data Science Accelerate Drug Discovery Processes?
June 4, 2024 by
In this contributed article, April Miller, senior IT and cybersecurity writer for ReHack Magazine, describes how thoughtfully applied data science principles and tools empower modern researchers to find new, viable treatment methods for various diseases and ailments. Humans will always be essential to drug discoveries, but the fascinating examples here and elsewhere show the power of using purposeful data analytics to meet shared goals.
AI Startup Jivi’s LLM Beats OpenAI’s GPT-4 & Google’s Med-PaLM 2 in Answering Medical Questions
June 1, 2024 by
A purpose-built medical LLM developed by Jivi, an Indian startup co-founded by former BharatPe Chief Product Officer Ankur Jain, has claimed the number one slot on the Open Medical LLM Leaderboard.
Where Artificial Intelligence Is Making a Difference in Healthcare
April 18, 2024 by
In this contributed article, Rajesh Viswanathan, Chief Technology Officer for Inovalon, discusses how for the past year, AI was at the center of conversations throughout healthcare. While the potential for AI to revolutionize healthcare is clear, from care delivery to enhancing operational efficiencies and accelerating research, many organizations are still figuring out where to begin.
Quantum-Enhanced Generative AI Generates Viable Cancer Drug Candidates
March 15, 2024 by
Zapata Computing, Inc., the Industrial Generative AI company, announced that its scientists, in collaboration with Insilico Medicine, the University of Toronto, and St. Jude Children’s Research Hospital have demonstrated the first instance of a generative model running on quantum hardware outperforming state-of-the-art classical models in generating viable cancer drug candidates. The research points to a promising future of hybrid quantum generative AI for drug discovery using today’s quantum devices.
Using Clinician Big Data to Alleviate a Struggling Workforce
March 2, 2024 by
In this contributed article, Charlie Lougheed, CEO and co-founder of Axuall, explains why healthcare needs to adjust its thinking and in what ways clinician big data can make impactful changes throughout the healthcare industry, from credentialing to attrition.
The Future of Computing: Harnessing Molecules for Sustainable Data Management
February 23, 2024 by
In this contributed article, Erfane Arwani, founder and CEO of Biomemory, discusses how molecular computing (using molecules rather than traditional silicon chips for computational tasks) could be a critical component in revolutionizing data storage, despite the exponential growth of AI.
